ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Every regulatory approval announcement on NSE and BSE that our alert engine sent, newest first. Each one has its own page with the summary, the key figures and the original filing.
Time
417 announcements with these filters
Equitas Small Finance Bank received RBI approval for Mirae Asset Mutual Fund to acquire up to 9.50% stake. The approval remains valid for one year.
Jainik Power Cables obtained key BIS certifications for its aluminium conductors and power cables. This regulatory milestone enables the company to commence large-scale commercial manufacturing operations.
Cochin Shipyard received government approval to extend Shri Jose V J's additional charge as Chairman & Managing Director for three months. This ensures leadership continuity during the transition.
India Pesticides Limited received EU Technical Equivalence approval for its Fungicide product. This regulatory milestone enables European market access and strengthens the company's global export strategy.
SBI Life Insurance Company appointed Mr. Ramesh Venkateshamurthy as Deputy Chief Executive Officer effective May 29, 2026. This leadership change strengthens the company's senior management team.
Lupin received U.S. FDA approval for its Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride tablets. The product targets a USD 132.8 million market.
Broach Lifecare Hospital received a 5-year permanent registration certificate from the Government of Gujarat. This expands Bharuch Hospital's bed capacity from 25 to 50.
Shreeji Shipping Global received Income Tax Department approval for the Tonnage Tax Scheme. Effective from FY2025-26, this move enhances long-term tax visibility and profitability.
Indoco Remedies received EU GMP certification from German Health Authority for its Baddi plant. This approval validates compliance with European standards for international markets.
Corona Remedies received EU-GMP certification for its Hormone facility and renewed approval for its OSD plant. These accreditations support the company's global pharmaceutical market expansion.
Wockhardt received CDSCO marketing authorization for its breakthrough antibiotic, ZAYNICH, in India. The drug targets complicated urinary tract infections, addressing significant unmet medical needs in antibiotic resistance.
Gretex Industries applied for RBI approval to acquire 98% of NBFC Arpan Tie-Up Private Limited for ₹5.90 Crore. The transaction expands its financial services footprint.
Zydus Lifesciences received US FDA Priority Review for its saroglitazar NDA. The PDUFA target action date is set for November 27, 2026, boosting product pipeline visibility.
EPL Limited received CCI approval for its amalgamation with Indovida India Private Limited. This regulatory milestone clears a major hurdle for the proposed merger.
Simplex Castings received RDSO approval for railway bogie prototype testing. The company expects ₹50 Crore in revenue this financial year, marking its return to core railway operations.
CSB Bank received RBI approval to appoint M P Chitale & Co and Sundaram & Srinivasan as Joint Statutory Auditors. The move ensures regulatory audit compliance.
Quadrant Future Tek received RDSO approval to commence passenger trials for its KAVACH 4.0 system. This milestone enables the final phase of securing commercial deployment certification.
MobiKwik received RBI's in-principle approval for a Payment Aggregator - Physical license. This authorization enables aggressive scaling of its offline merchant business toward a 10X growth target.
EKI Energy Services received a 25-year Category 'IV' electricity trading license from CERC. This authorization enables the company to conduct inter-state electricity trading across India.
NaBFID received RBI approval for an AD Category III license on May 22, 2026. This regulatory milestone enables the institution to expand its authorized activities.
Lemon Tree Hotels received CCI approval for acquiring Fleur Hotels shares and group internal restructuring. The detailed order formalizes regulatory clearance for these strategic transactions.
Lupin received Chinese regulatory approval for Oseltamivir Phosphate Oral Suspension, marking its first product entry into China. This milestone strengthens its global footprint in paediatric care.
Venus Remedies received Saudi FDA approval for Plerixafor, its first global oncology marketing authorization. This grants direct access to the GCC's largest pharmaceutical market.
360 ONE's subsidiary received SEBI's 'No Objection' to provide management and advisory services at GIFT City. This approval facilitates its expansion into international financial services.
Alembic Pharmaceuticals received USFDA final approval for Levothyroxine Sodium Tablets USP. The market size is estimated at ₹17942.4 Crore, strengthening the company's US generic portfolio.
AstraZeneca Pharma India received CDSCO approval to market Calquence for treating previously untreated mantle cell lymphoma. This expands the drug's Indian market indications for adult patients.
Hindalco announced that the CFIUS review for its AluChem acquisition is extended to July 2, 2026. The delay results from a partial U.S. federal government shutdown.
Restaurant Brands Asia received CCI approval for its ₹1499.99 Crore fundraising and ownership change. This regulatory clearance paves the way for the proposed acquisition and promoter reclassification.
Ashok Leyland's subsidiary received BSE's no-objection for its merger with NDL Ventures. The approval remains valid for six months, advancing the corporate restructuring process.
GOCL Corporation received a 'no adverse observations' letter from BSE for its merger with Hinduja National Power. This marks a key regulatory milestone toward final approval.